PEAK BIOTECH A/S — Credit Rating and Financial Key Figures
CVR number: 28892152
Bøgeskovvej 18 A, Munkegårde 3490 Kvistgård
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 10 434.44 | 9 118.47 | 8 782.27 | 5 934.53 | 22 438.95 |
| Costs of management | - 666.31 | - 979.79 | |||
| Costs of distribution | - 341.69 | - 425.41 | |||
| Employee benefit expenses | -2 449.49 | -2 477.08 | -2 369.47 | ||
| EBIT | 7 984.95 | 6 641.39 | 6 412.79 | 4 926.53 | 21 033.75 |
| Other financial income | 3.76 | 425.03 | |||
| Other financial expenses | -91.47 | - 105.32 | - 351.32 | - 596.69 | - 294.12 |
| Pre-tax profit | 7 897.25 | 6 536.07 | 6 061.47 | 4 329.84 | 21 164.66 |
| Income taxes | -1 737.97 | -1 438.71 | -1 346.49 | - 955.44 | -4 658.43 |
| Net earnings | 6 159.28 | 5 097.36 | 4 714.98 | 3 374.40 | 16 506.23 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 205.97 | 442.74 | |||
| Tangible assets total | 205.97 | 442.74 | |||
| Investments total | |||||
| Non-current other receivables | 48.82 | 48.82 | 48.82 | 48.66 | 70.26 |
| Long term receivables total | 48.82 | 48.82 | 48.82 | 48.66 | 70.26 |
| Raw materials and consumables | 810.42 | 253.78 | |||
| Finished products/goods | 1 081.64 | 459.33 | 516.25 | ||
| Inventories total | 1 081.64 | 459.33 | 516.25 | 810.42 | 253.78 |
| Current trade debtors | 4 163.03 | 1 053.38 | 1 894.27 | 13 116.59 | 20 083.35 |
| Current amounts owed by group member comp. | 13.29 | 764.48 | 1 548.48 | 2 605.31 | 2 586.60 |
| Prepayments and accrued income | 57.49 | 25.66 | 52.21 | 79.31 | 95.63 |
| Current other receivables | 4 339.13 | 1 808.89 | 1 899.87 | 593.45 | 1 506.34 |
| Current deferred tax assets | 9.67 | 7.25 | 5.44 | ||
| Short term receivables total | 8 582.61 | 3 659.66 | 5 400.27 | 16 394.66 | 24 271.91 |
| Cash and bank deposits | 10 577.86 | 9 983.22 | 21 164.84 | 28 294.95 | 23 680.07 |
| Cash and cash equivalents | 10 577.86 | 9 983.22 | 21 164.84 | 28 294.95 | 23 680.07 |
| Balance sheet total (assets) | 20 290.93 | 14 151.04 | 27 130.18 | 45 754.67 | 48 718.76 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 600.00 | 600.00 | 600.00 | 600.00 | 600.00 |
| Shares repurchased | 4 500.00 | 5 100.00 | 450.00 | 450.00 | 7 500.00 |
| Other reserves | -7 500.00 | ||||
| Retained earnings | - 819.00 | 240.28 | 4 887.65 | 9 152.63 | 5 027.03 |
| Profit of the financial year | 6 159.28 | 5 097.36 | 4 714.98 | 3 374.40 | 16 506.23 |
| Shareholders equity total | 10 440.28 | 11 037.65 | 10 652.63 | 13 577.03 | 22 133.27 |
| Provisions | 6.64 | 11.47 | |||
| Non-current liabilities total | |||||
| Advances received | 5 486.51 | 55.61 | |||
| Current trade creditors | 1 334.18 | 811.97 | 484.23 | 2 566.03 | 3 204.70 |
| Short-term deferred tax liabilities | 1 444.04 | 1 424.33 | 1 504.40 | 2 276.08 | 5 596.95 |
| Other non-interest bearing current liabilities | 1 585.93 | 821.49 | 2 509.58 | 3 948.42 | 11 266.35 |
| Accruals and deferred income | 11 979.34 | 23 380.48 | 6 506.03 | ||
| Current liabilities total | 9 850.65 | 3 113.39 | 16 477.55 | 32 170.99 | 26 574.02 |
| Balance sheet total (liabilities) | 20 290.93 | 14 151.04 | 27 130.18 | 45 754.67 | 48 718.76 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.